|
RNF8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.15100000039637E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67243996429534E-12 |
| Normal-vs-Stage2 |
8.293600E-01 |
| Normal-vs-Stage3 |
2.865600E-01 |
| Normal-vs-Stage4 |
9.204400E-04 |
| Stage1-vs-Stage2 |
2.464000E-01 |
| Stage1-vs-Stage3 |
1.393020E-01 |
| Stage1-vs-Stage4 |
5.503200E-01 |
| Stage2-vs-Stage3 |
7.364400E-01 |
| Stage2-vs-Stage4 |
3.311800E-01 |
| Stage3-vs-Stage4 |
2.907600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.93510000004549E-06 |
| Normal-vs-AfricanAmerican |
9.73489999722688E-09 |
| Normal-vs-Asian |
4.172200E-02 |
| Caucasian-vs-AfricanAmerican |
3.318000E-01 |
| Caucasian-vs-Asian |
8.355400E-01 |
| AfricanAmerican-vs-Asian |
3.818200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05819999984824E-07 |
| Normal-vs-Female |
1.755790E-03 |
| Male-vs-Female |
1.815700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.69819999571186E-08 |
| Normal-vs-Extreme_Weight |
8.81499999993984E-07 |
| Normal-vs-Obese |
5.117700E-02 |
| Normal-vs-Extreme_Obese |
3.57670000000754E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.420000E-01 |
| Normal_Weight-vs-Obese |
1.659030E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.157200E-01 |
| Extreme_Weight-vs-Obese |
1.754830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.476000E-01 |
| Obese-vs-Extreme_Obese |
7.103800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.783000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.95840010874804E-10 |
| Normal-vs-Age(61-80Yrs) |
6.18559999999713E-05 |
| Normal-vs-Age(81-100Yrs) |
1.26430000002564E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.292160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.340000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.308100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.422400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.643800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.367700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.41591208044656E-12 |
| Normal-VS-Type2 PRCC |
2.360100E-02 |
| Normal-VS-KIRP CIMP |
9.969600E-01 |
| Normal-VS-Unclassified PRCC |
2.37119999968449E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.962200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.475700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.066400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.525600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.184800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.159700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.425000E-04 |
| Normal-vs-N1 |
1.202760E-01 |
| Normal-vs-N2 |
1.467510E-02 |
| N0-vs-N1 |
1.173650E-01 |
| N0-vs-N2 |
9.045000E-01 |
| N1-vs-N2 |
2.784800E-01 |
|
|
